Top news of the week: 31.01.2023.
China approves two domestically developed COVID drugs
China has approved two domestically developed oral medicines for COVID-19 patients with mild symptoms, the National Medical Products Administration said on Sunday.
Paxlovid sales forecasts may change with Pfizer view on China
Clarity from Pfizer Inc this week on whether China's relaxation of its Zero-COVID policy and the surge in infections there will lead to a spike in demand for its antiviral Paxlovid could ...
Japan will continue to monitor COVID situation in China, govt says
Japan will continue to monitor the COVID-19 situation in China and deal "flexibly" with border control measures, Chief Cabinet Secretary Hirokazu Matsuno said on Monday.
J&J expects inflation, China COVID hit to carry into 2023
Johnson & Johnson on Tuesday said it sees the impact from high inflation carrying into 2023 and expects China's major COVID-19 outbreak to dent sales at its medical devices unit in the ...
China says COVID deaths, severe cases have fallen over 70% since peak
Critically ill COVID-19 cases in China are down 72% from a peak early this month while daily deaths among COVID-19 patients in hospitals have dropped 79% from their peak, the Center for ...
Abbott's medical device sales hit by China curbs, supply-chain issues
Abbott Laboratories on Wednesday reported lower-than-expected medical device sales in the fourth quarter as COVID-19 curbs in China and supply-chain issues hit its international operations, ...
Federal watchdog finds problems with NIH oversight of grant funding bat virus research in China
Report resulting from 18-month audit also notes that EcoHealth Alliance overreported $90,000 in expenses
Pfizer forecasts steep fall in 2023 sales of COVID products
Pfizer Inc on Tuesday forecast a bigger-than-expected drop in sales of its COVID-19 vaccine and treatment in 2023, intensifying investor concerns over demand for the products as governments ...